Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
Ben Ho, Pascal D. Johann, Yura Grabovska, et al.
Neuro-Oncology (2019) Vol. 22, Iss. 5, pp. 613-624
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

The SWI/SNF complex in cancer — biology, biomarkers and therapy
Priya Mittal, Charles W.M. Roberts
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 435-448
Open Access | Times Cited: 472
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 137
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy
Chantel Cacciotti, Adam Fleming, Vijay Ramaswamy
The Journal of Pathology (2020) Vol. 251, Iss. 3, pp. 249-261
Open Access | Times Cited: 74
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
Anthony P. Y. Liu, Bryan Li, Elke Pfaff, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 5, pp. 771-785
Open Access | Times Cited: 60
2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist
Cillian McNamara, Kshitij Mankad, Stefanie Thust, et al.
Neuroradiology (2022) Vol. 64, Iss. 10, pp. 1919-1950
Closed Access | Times Cited: 53
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
Garrett W. Cooper, Andrew L. Hong
Cancers (2022) Vol. 14, Iss. 15, pp. 3645-3645
Open Access | Times Cited: 43
Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation
Serap Erkek, Pascal D. Johann, Martina Finetti, et al.
Cancer Cell (2018) Vol. 35, Iss. 1, pp. 95-110.e8
Open Access | Times Cited: 75
Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases
Dörthe Holdhof, Pascal D. Johann, Michael Spohn, et al.
Acta Neuropathologica (2020) Vol. 141, Iss. 2, pp. 291-301
Open Access | Times Cited: 65
Current status and future prospects of nanomedicine for arsenic trioxide delivery to solid tumors
Marthe Sönksen, Kornelius Kerl, Hana Bunzen
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 374-398
Open Access | Times Cited: 49
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials
Santhosh A. Upadhyaya, Giles Robinson, Arzu Onar‐Thomas, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 10, pp. 2879-2889
Open Access | Times Cited: 48
ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
Aniello Federico, Christian Thomas, Katarzyna Miśkiewicz, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 697-711
Open Access | Times Cited: 28
Pathology of the Tumors of the Central Nervous System
Redi Bumci, Ioannis Parthymos, Constantinos Zamboglou, et al.
Springer eBooks (2023), pp. 71-110
Closed Access | Times Cited: 22
The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target
Sophie M. Navickas, Katherine A. Giles, Kate H. Brettingham‐Moore, et al.
Oncogene (2023) Vol. 42, Iss. 31, pp. 2363-2373
Open Access | Times Cited: 21
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Elizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Neoplasia (2023) Vol. 37, pp. 100880-100880
Open Access | Times Cited: 19
Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics
Cody L. Nesvick, Lucie Lafay‐Cousin, Aditya Raghunathan, et al.
Journal of Neuro-Oncology (2020) Vol. 150, Iss. 1, pp. 47-56
Open Access | Times Cited: 46
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
Giada Del Baldo, Roberto Carta, Iside Alessi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
Karolina Nemes, Pascal D. Johann, Stefanie Tüchert, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 479-498
Open Access | Times Cited: 24
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors
Jasmin Bartl, Marco Antônio Zanini, Flavia Bernardi, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
Irene Paassen, Justin Williams, Carla Ríos Arceo, et al.
Oncogene (2023) Vol. 42, Iss. 20, pp. 1661-1671
Open Access | Times Cited: 13
Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115727-115727
Closed Access | Times Cited: 13
Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases
Giuseppe Broggi, Francesca Gianno, Doron Theodore Shemy, et al.
Journal of Neuro-Oncology (2022) Vol. 157, Iss. 1, pp. 1-14
Closed Access | Times Cited: 21
Infants and Newborns with Atypical Teratoid Rhabdoid Tumors (ATRT) and Extracranial Malignant Rhabdoid Tumors (eMRT) in the EU-RHAB Registry: A Unique and Challenging Population
Karolina Nemes, Pascal D. Johann, Mona Steinbügl, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2185-2185
Open Access | Times Cited: 20
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 5, pp. 715-726
Open Access | Times Cited: 19
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Santhosh A. Upadhyaya, Olivia Campagne, Catherine A. Billups, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 2, pp. 386-397
Open Access | Times Cited: 19
Leptomeningeal dissemination in pediatric brain tumors
Carolina Cocito, Brice Martin, Alexandra Giantini-Larsen, et al.
Neoplasia (2023) Vol. 39, pp. 100898-100898
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top